Antiobesity medications tirzepatide and semaglutide offer long-term health benefits but are not cost-effective.
Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback